Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy

aDepartment of Oncologic Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium

bInstitute of Interdisciplinary Research (IRIBHM) and ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles, Bruxelles, Belgium

cDepartment of Endocrinology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium

Correspondence to Christiane Jungels, Department of Oncologic Medicine, Institut Jules Bordet, Rue Meylemeersch 90, 1070 Brussels, Belgium. Tel: +32 25413111; fax: +32 25413239; e-mail: [email protected]

留言 (0)

沒有登入
gif